|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02506 XUNFEIHEALTH
Nominal 
() | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 229,205 | 17.824% | 556,125 | 471,860 | 372,452 |
| Cost of Sales | (108,007) | 15.917% | (241,471) | (241,191) | (184,723) |
| Gross Profit | 121,198 | 19.578% | 314,654 | 230,669 | 187,729 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (8,402) | 139.510% | (6,187) | (8,602) | (628) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (18,735) | 4595.489% | (3,901) | (1,440) | (6,268) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (163,289) | 29.051% | (186,915) | (244,100) | (110,970) | |
| Taxation | 29,551 | 44.186% | 32,691 | 35,505 | 21,569 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,085 | -52.071% | 9,382 | 19,195 | 5,694 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (129,653) | 32.960% | (144,842) | (189,400) | (83,707) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,123) | -73.344% | (6,749) | (2,547) | 1,088 |
| Depreciation & Amortisation | 23,458 | 23.262% | 41,960 | 54,232 | 36,943 |
| Directors' Emoluments | 9,742 | -33.773% | 29,425 | 29,402 | 12,457 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -114.000 | 29.545% | -130.000 | -171.000 | -90.000 |
| DPS (cts) | -- | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (2.829) | (1.026) | (0.564) |
| NBV per share ($) | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 23/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -129,653,000 |
| %Change | 32.960% |
| EPS / (LPS) | RMB -1.140 |
| NBV Per Share (¥) | RMB -- |